Cefuroxime (sodium salt)

Cefuroxime (sodium salt)

CAT N°: 23627
Price:

From 102.00 86.70

Cefuroxime is a cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria including S. pyogenes, S. pneumoniae, S. viridans, E. coli, P. mirabilis, H. influenzae, and N. gonorrhoeae (mean MICs = 0.005-8.2 ?g/ml).{40366} Like other cephalosporins, cefuroxime inhibits peptidoglycan crosslinking and bacterial cell wall synthesis.{40367} It is resistant to hydrolysis by bacterial ?-lactamases, increasing its efficacy against ?-lactamase producing Gram-negative bacteria.{40368} Cefuroxime is protective against Gram-positive and Gram-negative infections in vivo with mean ED50 values ranging from 2 to 35 and 1 to 55 mg/kg, in mice and rats, respectively.{40369} Formulations containing cefuroxime have been used to treat urinary tract infections.{40370}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (6R,7R)-3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, monosodium salt
  • Correlated keywords
    • 55268-75-2 640/359 Anaptivan Biociclin Biofurex Bioxima Cefamar Cefoprim Cefumax Cefurex Cefurin Curocef Curoxim Duxima Gibicef Ipacef Kefurox Kesint Lampsporin Medoxim Novocef Spectrazol Spectrazole Ultroxim Zinacef Streptococcus streptococci Escherichia Proteus Haemophilus Neisseria
  • Product Overview:
    Cefuroxime is a cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria including S. pyogenes, S. pneumoniae, S. viridans, E. coli, P. mirabilis, H. influenzae, and N. gonorrhoeae (mean MICs = 0.005-8.2 ?g/ml).{40366} Like other cephalosporins, cefuroxime inhibits peptidoglycan crosslinking and bacterial cell wall synthesis.{40367} It is resistant to hydrolysis by bacterial ?-lactamases, increasing its efficacy against ?-lactamase producing Gram-negative bacteria.{40368} Cefuroxime is protective against Gram-positive and Gram-negative infections in vivo with mean ED50 values ranging from 2 to 35 and 1 to 55 mg/kg, in mice and rats, respectively.{40369} Formulations containing cefuroxime have been used to treat urinary tract infections.{40370}

We also advise you